Author Archives: JAIDS

Interobserver Variation of the Rapid Test SD Bioline HIV-1/2 3.0 for HIV Type Discrimination: …

No abstract available

Posted in Journal Watch | Comments closed

A Run-in Period Is Needed in Randomized Controlled Trials of Directly Observed Antiretroviral…

No abstract available

Posted in Journal Watch | Comments closed

Dynamics of HIV DNA and Residual Viremia in Patients Treated With a Raltegravir-Containing…

No abstract available

Posted in Journal Watch | Comments closed

Illustration of a Measure to Combine Viral Suppression and Viral Rebound in Studies of HIV…

Abstract: Viral load is an important tool for assessing antiretroviral treatment efficacy.

Posted in Journal Watch | Comments closed

The Impact of Transfer Patients on the Local Cascade of HIV Care Continuum

Background: The Cascade of Care (COC) visualizes stages of HIV care progression within a population.

Posted in Journal Watch | Comments closed

High HIV, HPV, and STI Prevalence Among Young Western Cape, South African Women: EVRI HIV…

Background: This study sought to assess the feasibility of conducting a phase III HIV prevention trial using a multivalent human papillomavirus (HPV) vaccine (Gardasil; Merck, Whitehouse Station, NJ).

Posted in Journal Watch | Comments closed

Monitoring Outcomes for Newly Diagnosed and Prevalent HIV Cases Using a Care Continuum Created…

Background: The HIV care continuum has been used to show the proportion of persons living with HIV/AIDS (PWHA) who are engaged in each stage of HIV care.

Posted in Journal Watch | Comments closed

HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial…

Background: Traditional cardiovascular disease risk factors (CVDRFs) increase the risk of acute myocardial infarction (AMI) among HIV-infected (HIV+) participants.

Posted in Journal Watch | Comments closed

Viremia Copy-Years as a Predictive Marker of All-Cause Mortality in HIV-1–Infected Patients…

Background: Viremia copy-years (VCY) has been reported as a short-term predictor of mortality.

Posted in Journal Watch | Comments closed

Pregnancy and Contraceptive Use Among Women Participating in the FEM-PrEP Trial

Background: Pregnancy among study participants remains a challenge for trials of new HIV prevention agents despite promotion and provision of contraception.

Posted in Journal Watch | Comments closed

Efficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia: …

Background: Roughly 4% of the 1.25 million patients on antiretroviral therapy (ART) in Asia are using second-line therapy.

Posted in Journal Watch | Comments closed

Country of Birth Does Not Influence Long-term Clinical, Virologic, and Immunological Outcome of…

Background: Immigrant HIV-infected adults in industrialized countries show a poorer clinical and virologic outcome compared with native patients.

Posted in Journal Watch | Comments closed

Rates and Correlates of Antiretroviral Therapy Use and Virologic Suppression Among Perinatally…

Objective: To measure rates of antiretroviral therapy (ART) use and virologic suppression among perinatally HIV-infected youth (PIY) and behaviorally HIV-infected youth (BIY) linked to care in the United States and examine the effects of demographic, biomedical, and psychosocial factors on those rates.

Posted in Journal Watch | Comments closed

Comparison of Analytical and Clinical Performances of the Digene HC2 HPV DNA Assay and the…

Objectives: To compare the Hybrid Capture 2 human papillomaviruses (HPV) DNA assay (HC2) and the INNO-LiPA HPV Genotyping Extra assay (INNO-LiPA) for cervical cancer screening in HIV-1–infected African women.

Posted in Journal Watch | Comments closed